130 related articles for article (PubMed ID: 11160483)
1. Diagnosis of a multifocal B cell lymphoma with preceding demyelinating central nervous system lesions by single voxel proton MR spectroscopy.
Kuhlmann T; Schröter A; Dechent P; Weber F; Rustenbeck HH; Füzesi L; Brück W; Ehrenreich H; Frahm J
J Neurol Neurosurg Psychiatry; 2001 Feb; 70(2):259-62. PubMed ID: 11160483
[TBL] [Abstract][Full Text] [Related]
2. Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination.
Thomas PK; Walker RW; Rudge P; Morgan-Hughes JA; King RH; Jacobs JM; Mills KR; Ormerod IE; Murray NM; McDonald WI
Brain; 1987 Feb; 110 ( Pt 1)():53-76. PubMed ID: 3026554
[TBL] [Abstract][Full Text] [Related]
3. [Demyelinating pseudotumoral lesion prior to a primary cerebral lymphoma].
Alarcia R; Ara JR; Marta E; Barrena MR; Giménez-Más JA; Capablo JL; Serrano M
Rev Neurol; 2000 Nov 16-30; 31(10):955-8. PubMed ID: 11244691
[TBL] [Abstract][Full Text] [Related]
4. Rapid proton fat-water spectroscopy for the characterization of non-CNS lesions in vivo.
Riedy G
Clin Imaging; 2003; 27(3):145-9. PubMed ID: 12727049
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
Zacharia TT; Law M; Naidich TP; Leeds NE
J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
[TBL] [Abstract][Full Text] [Related]
6. The nonspecific nature of proton spectroscopy in brain masses in children: a series of demyelinating lesions.
Pandya HG; Wilkinson ID; Agarwal SK; Griffiths PD
Neuroradiology; 2005 Dec; 47(12):955-9. PubMed ID: 15776226
[TBL] [Abstract][Full Text] [Related]
7. [Proton MR spectroscopy (1H-MRS): clinical usefulness for MR diagnosis of central nervous system].
Ida M; Nakamura K; Arai T; Tokuyama T; Onishi T
No To Shinkei; 2002 Nov; 54(11):935-41. PubMed ID: 12512118
[No Abstract] [Full Text] [Related]
8. Proton magnetic resonance spectroscopy and magnetic resonance imaging findings in a patient with central nervous system paracoccidioidomycosis.
Faria AV; Dabus GC; Zanardi VA; Cendes F
J Neuroimaging; 2004 Oct; 14(4):377-9. PubMed ID: 15358962
[TBL] [Abstract][Full Text] [Related]
9. Nuclear magnetic resonance imaging in central nervous system disease.
Buonanno FS; Kistler JP; DeWitt LD; Davis KR; DeLaPaz R; New PF; Burt CT; Brady TJ
Semin Nucl Med; 1983 Oct; 13(4):329-38. PubMed ID: 6648538
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging of the central nervous system.
Norman D; Brant-Zawadzki M
Res Publ Assoc Res Nerv Ment Dis; 1985; 63():259-69. PubMed ID: 4023403
[TBL] [Abstract][Full Text] [Related]
11. Histogram analysis of apparent diffusion coefficient maps for differentiating primary CNS lymphomas from tumefactive demyelinating lesions.
Lu SS; Kim SJ; Kim N; Kim HS; Choi CG; Lim YM
AJR Am J Roentgenol; 2015 Apr; 204(4):827-34. PubMed ID: 25794073
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy in a pathologically confirmed acute demyelinating lesion.
Silver NC; Barker RA; MacManus DG; Barker GJ; Thom M; Thomas DG; McDonald WI; Miller DH
J Neurol; 1997 Mar; 244(3):204-7. PubMed ID: 9050963
[No Abstract] [Full Text] [Related]
13. Magnetic resonance imaging of the central nervous system.
Bradley WG
Neurol Res; 1984 Sep; 6(3):91-106. PubMed ID: 6151140
[TBL] [Abstract][Full Text] [Related]
14. [NMR: basic and clinical researches in diagnosis of CNS lesions].
Yamaura A
No To Shinkei; 1985 May; 37(5):433-43. PubMed ID: 2992554
[No Abstract] [Full Text] [Related]
15. [Tumor-like inflammatory demyelinating diseases of the central nervous system with relapse onset: a case report and review].
Qi XL; Chen J; Zheng RL; Li Y; Huang YN; Yuan Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):588-9. PubMed ID: 19829680
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy differentiates tumefactive demyelinating lesions from gliomas.
Ikeguchi R; Shimizu Y; Abe K; Shimizu S; Maruyama T; Nitta M; Abe K; Kawamata T; Kitagawa K
Mult Scler Relat Disord; 2018 Nov; 26():77-84. PubMed ID: 30237108
[TBL] [Abstract][Full Text] [Related]
17. [Demyelinating disease affecting both central and peripheral nervous system].
Carra-Dallière C; Mania A; Carlander B; Camu W; Juntas-Morales R
Rev Neurol (Paris); 2011 Dec; 167(12):921-5. PubMed ID: 21596409
[TBL] [Abstract][Full Text] [Related]
18. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis.
Tan HM; Chan LL; Chuah KL; Goh NS; Tang KK
Br J Radiol; 2004 Feb; 77(914):153-6. PubMed ID: 15010391
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
[TBL] [Abstract][Full Text] [Related]
20. Neuroimaging in postinfectious demyelination and nutritional disorders of the central nervous system.
Lim CC
Neuroimaging Clin N Am; 2011 Nov; 21(4):843-58, viii. PubMed ID: 22032502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
